TOBI (Novartis Pharmaceuticals Corporation)
Welcome to the PulseAid listing for the TOBI drug offered from Novartis Pharmaceuticals Corporation. This Aminoglycoside Antibacterial [EPC],Aminoglycosides [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Novartis Pharmaceuticals Corporation |
NON-PROPRIETARY NAME: | Tobramycin |
SUBSTANCE NAME: | TOBRAMYCIN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Aminoglycoside Antibacterial [EPC],Aminoglycosides [Chemical/Ingredient] |
ROUTE: | ORAL |
DOSAGE FORM: | SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1997-12-22 |
END MARKETING DATE: | 0000-00-00 |
TOBI HUMAN PRESCRIPTION DRUG Details:
Item Description | TOBI from Novartis Pharmaceuticals Corporation |
LABELER NAME: | Novartis Pharmaceuticals Corporation |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 300(mg/5mL) |
START MARKETING DATE: | 1997-12-22 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0078-0494_00c22bc4-d60e-4ff1-a572-22d871717c19 |
PRODUCT NDC: | 0078-0494 |
APPLICATION NUMBER: | NDA050753 |
Other TOBRAMYCIN Pharmaceutical Manufacturers / Labelers: